cebranopadol (TRN-228) - Tris Pharma
ALLEVIATE-2: A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy (clinicaltrials.gov) - Jan 9, 2026 - P3 | N=240 | Completed | Sponsor: Tris Pharma, Inc. | Recruiting ➔ Completed 
Trial completion • Pain
http://clinicaltrials.gov/ct2/show/NCT06423703
 
Jan 9, 2026
 
Prev Next